Tradestie Institutional Equity Comparison Engine
DARE vs MBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MBIO Overall Edge
MBIO Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mustang Bio, Inc. (MBIO) driven by superior Growth & Margin, Momentum & Technical while DARE counters with relative strength in Valuation. Fundamentally, DARE trades at 1.3x Forward P/E with -813.4% operating margin (+499.6% YoY revenue) versus MBIO at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, DARE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DARE
DARE 1.3x vs MBIO N/M Fwd P/E
Growth & Margin Winner
MBIO
Op Margin -813.4% vs 0.0% ยท YoY +499.6% vs +0.0%
Momentum & Technical Winner
MBIO
1Y -69.1% vs -68.4% ยท 52W Pos 0% vs 3%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DARE
NASDAQ
Dare Bioscience, Inc. Common Stock
Pharmaceutical Preparations
$0.58
-11.13% 1D
Market Cap
$12.9M
1M Return
-19.38%
1Y Return
-69.09%
Forward P/E
1.3x
Unified AI Score
45.7 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 50.0
Mom 64.0
MBIO
NASDAQ
Mustang Bio, Inc.
Pharmaceutical Preparations
$0.39
-2.46% 1D
Market Cap
$3.2M
1M Return
+3.22%
1Y Return
-68.44%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 40.0
Fund 49.0
Flow 50.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DARE -69.09%
MBIO -68.44%
Spread: +0.94 pp (MBIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
DARE TTM Op. Margin: -813.4%
MBIO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DARE vs MBIO. Trailing 12-month operating profitability (DARE -813.4% vs MBIO 0.0%) and valuation multiples (DARE 1.3x vs MBIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DARE | MBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.9M | $3.2M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 1.3x | N/M | Lower Multiple | DARE |
| Forward P/E Ratio Valuation | 1.3x | N/M | Lower Multiple | DARE |
| Revenue Growth (YoY) Growth | +499.6% | +0.0% | Higher Growth | DARE |
| Operating Margin (TTM) Profitability | -813.4% | 0.0% | Higher Margin | MBIO |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -2543.1% | -43.1% | Higher ROE | MBIO |
| 52-Week Range Position Momentum | 0% ($1โ$4) | 3% ($0โ$1) | Stronger Trend | MBIO |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 62% Vol | 0.68ฮฒ ยท 87% Vol | Lower Realized Risk | DARE |
| Unified Institutional Score Composite Signal | 45.7 / 100 (HOLD) | 42.9 / 100 (HOLD) | Higher Composite | DARE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DARE vs MBIO Buy Guide
DARE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MBIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DARE nor MBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.